The United States government has confirmed plans to gradually withdraw funding for HIV and AIDS programmes in South Africa, marking a significant shift in one of the world’s largest public health partnerships and raising concerns about the future of disease prevention efforts across the country.
The decision affects funding provided through the President’s Emergency Plan for AIDS Relief (PEPFAR), a programme that has played a critical role in supporting South Africa’s fight against HIV for more than two decades. Until recently, the initiative contributed an estimated $400 million annually toward HIV prevention, treatment support, and healthcare services.
South Africa carries the world’s largest HIV burden, with more than eight million people living with the virus. For years, international partnerships, including support from the United States, have helped strengthen testing, treatment access, and community outreach programmes nationwide.
The announcement comes against the backdrop of increasingly strained relations between Pretoria and Washington under the administration of US President Donald Trump. American officials have linked the funding withdrawal to what they describe as South Africa’s failure to address policy concerns raised by Washington, including allegations regarding the treatment of the country’s white Afrikaner minority.
The South African government has repeatedly rejected claims of racial persecution, arguing that policies such as Black Economic Empowerment remain necessary tools to address inequalities created by decades of apartheid rule.
In a statement, South Africa’s Department of Health said it had not received formal communication regarding the latest funding decision but stressed that preparations for greater financial independence have been underway for some time.
Health authorities also sought to reassure the public that the country’s supply of life-saving antiretroviral medication remains secure. According to the department, the majority of HIV treatment programmes are funded directly by the South African government, while PEPFAR’s support has largely focused on complementary services and healthcare infrastructure.
US officials have described the move as part of a broader strategy to encourage self-sufficiency, arguing that South Africa, as a middle-income economy, has the capacity to sustain its own public health programmes without long-term dependence on foreign aid.
The latest development further deepens a diplomatic divide that has widened in recent years. Tensions escalated after Washington criticised South Africa’s domestic policies, its legal case against Israel at the International Court of Justice, and its diplomatic engagement with Iran.
Relations between the two governments have faced several setbacks, including a tense meeting between President Trump and President Cyril Ramaphosa, during which allegations of discrimination against white South Africans were openly debated. The United States also distanced itself from several engagements linked to South Africa’s presidency of the G20.
While government officials insist that essential HIV treatment services will continue uninterrupted, public health experts warn that the withdrawal of PEPFAR funding could place additional pressure on already stretched healthcare systems, particularly community-based programmes that rely heavily on international support.
As South Africa moves toward greater self-funding of its HIV response, the decision marks a pivotal moment in the country’s public health landscape and signals a new chapter in its increasingly complex relationship with the United States.